MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Canadian Journal of Health Technologies
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

660 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
660 works in the cohort · of 4,299,418page 8 of 14

Labels cover 1 of 660 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 660 of 660 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Darolutamide (Nubeqa)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Post-Market Drug Evaluation
Nicole Mittmann
2022· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · none
0
citations
aboutno affunlabeled
Talquetamab (Talvey)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Sotatercept (Winrevair)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Nivolumab
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Faricimab (Vabysmo)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Upadacitinib (Rinvoq)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affgemma · no categorygpt · no categorymodels split
Faricimab (Vabysmo)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Insulin icodec (Awiqli)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Optune (NovoTTF-200A)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ruxolitinib (Opzelura)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Colchicine (Myinfla)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ruxolitinib (Opzelura)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Aflibercept 8 mg/0.07 mL (Eylea HD)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Teclistamab (Tecvayli)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Iptacopan (Fabhalta)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Belumosudil (Rezurock)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Secukinumab (Cosentyx)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Mogamulizumab (Poteligeo)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Fostamatinib (Tavalisse)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Semaglutide (Rybelsus)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Selpercatinib (Retevmo)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Zolbetuximab for Injection (Vyloy)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Trastuzumab Deruxtecan (Enhertu)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pasireotide (Signifor LAR)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Durvalumab (Imfinzi)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Baricitinib (Olumiant)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Thank You to Our Readers and Contributors
Nicole Mittmann
2021· article· en· Canadian Journal of Health Technologies· Engineering
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Brentuximab Vedotin (Adcetris)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Venetoclax (Venclexta)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Aging in Place
CADTH
2024· article· en· Canadian Journal of Health Technologies· Social Sciences
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About